Centessa Insider Trades Signal Confidence as Pipeline Advances Toward Key FDA Approvals
Centessa insiders’ recent buy‑sell trades reveal strategic profit‑taking amid rising stock, yet continued buying signals confidence in its KRAS‑targeted pipeline and upcoming approvals.
- Centessa Pharmaceuticals PLC
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
4 minutes to read


